Placental transport and in vitro effects of Bisphenol A

Reproductive Toxicology

Volumn 30, Issue 1, 2010, Pages 131-137

  Mørck, Thit J ^a   Sorda, Giuseppina ^b   Bechi, Nicoletta ^b   Rasmussen, Brian S ^a   Nielsen, Jesper B ^c   Ietta, Francesca ^b   Rytting, Erik ^a   Mathiesen, Line ^a   Paulesu, Luana ^b   Knudsen, Lisbeth E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Bisphenol A; Dermal permeation; Endocrine disruptor; Fetal exposure; In vitro; Placental transport; Trophoblasts

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CASPASE 3; CHORIONIC GONADOTROPIN BETA SUBUNIT; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE; POLLUTANT;

ARTICLE; BEWO CELL; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; FEMALE; FETUS DEVELOPMENT; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MONOLAYER CULTURE; PLACENTA DEVELOPMENT; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PROTEIN EXPRESSION; SKIN PENETRATION; TISSUE CULTURE; TOXICOKINETICS; TROPHOBLAST; ANIMAL TESTING ALTERNATIVE; BIOSYNTHESIS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG EFFECTS; FETOMATERNAL TRANSFUSION; METABOLISM; PERFUSION; PLACENTA; POLLUTANT; PREGNANCY; RISK ASSESSMENT; SECRETION (PROCESS); SKIN; SKIN ABSORPTION; TOXICITY; TUMOR CELL LINE;

ANIMAL TESTING ALTERNATIVES; CASPASE 3; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PERFUSION; PHENOLS; PLACENTA; PREGNANCY; RISK ASSESSMENT; SKIN; SKIN ABSORPTION; BENZHYDRYL COMPOUNDS;

EID: 77954089848     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.02.007     Document Type: Article

References (55)

1. NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. NIH publication No. 08-5994. 2008. National Toxicology Programme, U.S Department of Health and Human Services, Center for the evaulation of risk to human reproduction.
2. European Communities. Updated European Risk Assessment Report 4,4'-isopropylidenediphenol (bisphenol A) CAS Number: 80-05-7 Einecs Number: 201-245-8 2008.
3. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
4. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002, 17:2839-2841.
5. Yamada H., Furuta I., Kato E.H., Kataoka S., Usuki Y., Kobashi G., et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol 2002, 16:735-739.
6. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002, 110:A703-A707.
7. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., et al. Maternal bisphenol-A levels at delivery: a looming problem?. J Perinatol 2008, 28:258-263.
8. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
9. Okada H., Tokunaga T., Liu X., Takayanagi S., Matsushima A., Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect 2008, 116:32-38.
10. Xu L.C., Sun H., Chen J.F., Bian Q., Qian J., Song L., et al. Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro. Toxicology 2005, 216:197-203.
11. Vivacqua A., Recchia A.G., Fasanella G., Gabriele S., Carpino A., Rago V., et al. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 2003, 22:275-284.
12. Takeuchi T., Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun 2002, 291:76-78.
13. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
14. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., vom Saal F.S. Exposure to bisphenol A advances puberty. Nature 1999, 401:763-764.
15. Munoz-de-Toro M., Markey C.M., Wadia P.R., Luque E.H., Rubin B.S., Sonnenschein C., et al. Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 2005, 146:4138-4147.
16. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 2000, 224:61-68.
17. Gioiosa L., Fissore E., Ghirardelli G., Parmigiani S., Palanza P. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice. Horm Behav 2007, 52:307-316.
18. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 2002, 68:121-146.
19. Nagao T., Saito Y., Usumi K., Yoshimura S., Ono H. Low-dose bisphenol A does not affect reproductive organs in estrogen-sensitive C57BL/6N mice exposed at the sexually mature, juvenile, or embryonic stage. Reprod Toxicol 2002, 16:123-130.
20. Ichihara T., Yoshino H., Imai N., Tsutsumi T., Kawabe M., Tamano S., et al. Lack of carcinogenic risk in the prostate with transplacental and lactational exposure to bisphenol A in rats. J Toxicol Sci 2003, 28:165-171.
21. Bode C.J., Jin H., Rytting E., Silverstein P.S., Young A.M. In vitro models for studying trophoblast transcellular transport. Methods Mol Med 2006, 122:225-239.
22. Liu F., Soares M.J., Audus K.L. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol 1997, 273:C1596-C1604.
23. Ramos A.J., Cantero M.R., Zhang P., Raychowdhury M.K., Green A., MacPhee D., et al. Morphological and electrical properties of human trophoblast choriocarcinoma, BeWo cells. Placenta 2008, 29:492-502.
24. Caniggia I., Taylor C.V., Ritchie J.W., Lye S.J., Letarte M. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 1997, 138:4977-4988.
25. Nakayama G.R., Caton M.C., Nova M.P., Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 1997, 204:205-208.
26. Moore M.K., Viselli S.M. Staining and quantification of proteins transferred to polyvinylidene fluoride membranes. Anal Biochem 2000, 279:241-242.
27. Poulsen M.S., Rytting E., Mose T., Knudsen L.E. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol In Vitro 2009, 23:1380-1386.
28. Ushigome F., Takanaga H., Matsuo H., Yanai S., Tsukimori K., Nakano H., et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000, 408:1-10.
29. Utoguchi N., Magnusson M., Audus K.L. Carrier-mediated transport of monocarboxylic acids in BeWo cell monolayers as a model of the human trophoblast. J Pharm Sci 1999, 88:1288-1292.
30. Mahar Doan K.M., Humphreys J.E., Webster L.O., Wring S.A., Shampine L.J., Serabjit-Singh C.J., et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J Pharmacol Exp Ther 2002, 303:1029-1037.
31. Mathiesen L., Mose T., Mørck T.J., Nielsen J.K., Nielsen L.K., Maroun L.L., et al. Quality assessment of placental perfusion protocol. Reprod Toxicol 2010, [Epub ahead of print].
32. Csanady G.A., Oberste-Frielinghaus H.R., Semder B., Baur C., Schneider K.T., Filser J.G. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch Toxicol 2002, 76:299-305.
33. Andersen D.N., Knudsen L.E., Cohr K.-H., Nielsen J.B. Transplacental transport of pesticides, analogy to percutaneous transport and modelling 2009, The Danish Environmental Protection Agency. Pesticide research, Copenhagen, [Report number 125].
34. Mathiesen L., Rytting E., Mose T., Knudsen L.E. Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium. Basic Clin Pharmacol Toxicol 2009, 105:181-187.
35. Nielsen J.B. Percutaneous penetration through slightly damaged skin. Arch Dermatol Res 2005, 296:560-567.
36. Nielsen J.B., Sorensen J.A., Nielsen F. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds. J Toxicol Environ Health A 2009, 72:315-323.
37. Vahakangas K., Myllynen P. Experimental methods to study human transplacental exposure to genotoxic agents. Mutat Res 2006, 608:129-135.
38. Atkinson D.E., Greenwood S.L., Sibley C.P., Fairban L.J. Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am J Physiol Cell Physiol 2003, 285:C584-C591.
39. Evseenko D.A., Paxton J.W., Keelan J.A. ABC drug transporter and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1357-R1365.
40. Utoguchi N., Chandorkar G.A., Avery M., Audus K.L. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol 2000, 14:217-224.
41. Miller M.J., Ahmed S., Bobrowski P., Haqqi T.M. The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta. BMC Complement Altern Med 2006, 6:13.
42. Rama S., Petrusz P., Rao A.J. Hormonal regulation of human trophoblast differentiation: a possible role for 17beta-estradiol and GnRH. Mol Cell Endocrinol 2004, 218:79-94.
43. Bechi N., Ietta F., Romagnoli R., Focardi S., Corsi I., Buffi C., et al. Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells. Toxicol Sci 2006, 93:75-81.
44. Yoshikawa Y., Hayashi A., Inai M., Matsushita A., Shibata N., Takada K. Permeability characteristics of endocrine-disrupting chemicals using an in vitro cell culture model, Caco-2 cells. Curr Drug Metab 2002, 3:551-557.
45. Jin H., Audus K.L. Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta 2005, 26(Suppl A):S96-S103.
46. Cousins I.T., Staples C.A., Klecka G.M., Mackay D. A multimedia assessment of the environmental fate of Bisphenol A. Hum Ecol Risk Assesment 2002, 8:1107-1135.
47. Young A.M., Allen C.E., Audus K.L. Efflux transporters of the human placenta. Adv Drug Deliv Rev 2003, 55:125-132.
48. Cheng M.H., Wang P.H. Placentation abnormalities in the pathophysiology of preeclampsia. Expert Rev Mol Diagn 2009, 9:37-49.
49. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., Lessey B.A. Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276.
50. Crocker I.P., Tansinda D.M., Baker P.N. Altered cell kinetics in cultured placental villous explants in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. J Pathol 2004, 204:11-18.
51. Kaddar N., Harthe C., Dechaud H., Mappus E., Pugeat M. Cutaneous penetration of bisphenol A in pig skin. J Toxicol Environ Health A 2008, 71:471-473.
52. Cartlidge P. The epidermal barrier. Semin Neonatol 2000, 5:273-280.
53. Chiou Y.B., Blume-Peytavi U. Stratum corneum maturation. A review of neonatal skin function. Skin Pharmacol Physiol 2004, 17:57-66.
54. Tansirikongkol A., Wickett R.R., Visscher M.O., Hoath S.B. Effect of vernix caseosa on the penetration of chymotryptic enzyme: potential role in epidermal barrier development. Pediatr Res 2007, 62:49-53.
55. Myren M., Mose T., Mathiesen L., Knudsen L.E. The human placenta-an alternative for studying foetal exposure. Toxicol In Vitro 2007, 21:1322-1340.